It's been a strong session for the All Ordinaries Index (ASX: XAO) and most ASX All Ords shares so far this Thursday. At present, the All Ords has gained a healthy 0.57%, lifting the index to back over 7,200 points.
But let's talk about two ASX All Ords shares that are doing even better than that, and have just hit new 52-week highs.
2 ASX All Ords shares at new 52-week highs today
Pro Medicus Limited (ASX: PME)
ASX All Ords healthcare share Pro Medicus is first up. This medical imaging company has had a lucrative, albeit volatile session today thus far. The company hit its new 52-week (and all-time record) high of $86.25 a share in early trading this morning, but soon after fell back into negative territory.
However, the Pro Medicus share price has since recovered a little and is back in the green, currently up 0.6% at $85.72 a share. This latest new high comes despite an absence of recent news from the company. Pro Medicus' last major announcement was back on 23 October, when the company revealed that it had signed a $16 million, eight-year contract with the US company South Shore Health.
Investors didn't seem too excited by this news last month. But since the start of November, they seem to have reconsidered, with the Pro Medicus share price now up a whopping 14.92% since the start of the month.
Today's gains put the Pro Medicus share price's performance over 2023 so far at a stunning 57.58%.
EML Payments Ltd (ASX: EML)
Our second ASX All Ords share minting a new high today is payments share EML. Like Pro Medicus, EML shares spiked in early trading to reach its new 52-week high.
The company topped out at $1.28 a share soon after market open this morning before falling back to earth somewhat. Even so, EML shares remain up a pleasing 2.09% at the time of writing at $1.22 each.
There hasn't been any fresh news out of EML Payments for more than two months now.
Even so, it appears the company is still benefitting from vastly improved sentiment following its full-year results announcement for FY2023 back in late August. As we covered at the time, these earnings saw EML report record revenue of $254.2 million, which was up 9% for the year.
Today's gains mean that the EML share price is now up a stinking 98.4% year to date.
